Panniculectomy With Umbilical Transposition in the Era of GLP-1 Receptor Agonists: The Impact of Weight Loss Modality on Post-Operative Outcomes

Abstract Background Panniculectomy is performed to address excess infraumbilical skin and soft tissue following weight loss. Weight loss can be achieved through lifestyle modifications, bariatric surgery, and pharmacologic therapies, such as glucagon-like peptide-1 (GLP-1) agonists. The impact of weight loss modality on post-operative outcomes remains unclear. Objectives To evaluate whether the method of weight loss influences post-operative outcomes following panniculectomy. Methods A single-center retrospective review was conducted of patients who underwent panniculectomy between 2021 and 2025. Patients were grouped into four cohorts: lifestyle modifications alone, bariatric surgery, GLP-1 agonist therapy, or combined bariatric surgery and GLP-1 agonist therapy. Patients receiving abdominoplasty with extensive undermining and rectus plication were excluded. Variables of interest included patient demographics, weight loss history, comorbidities, wound healing complications, surgical site infection, hematoma/seroma, and hospital utilization. Multivariate logistic regression was performed to analyze post-operative complications and healthcare utilization, with statistical significance set at p < 0.05. Results A total of 281 patients met inclusion criteria (lifestyle modifications: n=53 (18.9%); bariatric surgery: n=184 (65.5%); GLP-1 agonist therapy: n=20 (7.1%); and combined bariatric surgery and GLP-1 agonist therapy: n=24 (8.5%)). Multivariate analysis showed no statistically significant differences in post-operative outcomes, including wound complications, surgical site infections, seroma/hematoma, or hospital utilization. Conclusions Post-operative outcomes following panniculectomy may be similar regardless of weight loss method. Pre-operative GLP-1 agonist therapy, alone or combined with bariatric surgery, was not associated with increased post-operative complications or healthcare utilization. Our results can help guide risk stratification and decision-making for individuals pursuing panniculectomy after weight loss.

Authors

Institutions

Publication Details

Journal
Aesthetic Surgery Journal Open Forum
Published
2026-10-15
DOI
https://doi.org/10.1093/asjof/ojag206
Primary Topic
Body Contouring and Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Panniculectomy With Umbilical Transposition in the Era of GLP-1 Receptor Agonists: The Impact of Weight Loss Modality on Post-Operative Outcomes

Kasra N. Fallah, Ravinder Bamba, George S. Corpuz, Richard Jason VonDerHaar et al.
Aesthetic Surgery Journal Open Forum
Body Contouring and Surgery
article

Panniculectomy With Umbilical Transposition in the Era of GLP-1 Receptor Agonists: The Impact of Weight Loss Modality on Post-Operative Outcomes

Kasra N. Fallah, Ravinder Bamba, George S. Corpuz, Richard Jason VonDerHaar, Louis Massoud, Aladdin H. Hassanein, Ivan Hadad, Rachel M. Danforth, Dillon Mobasser, Parhom N. Towfighi, Nikhi Paul Singh, Mary E. Lester, Angad S. Sidhu, Ryan Harmelink, Aniffa S Kouton
article en

Abstract

Abstract Background Panniculectomy is performed to address excess infraumbilical skin and soft tissue following weight loss. Weight loss can be achieved through lifestyle modifications, bariatric surgery, and pharmacologic therapies, such as glucagon-like peptide-1 (GLP-1) agonists. The impact of weight loss modality on post-operative outcomes remains unclear. Objectives To evaluate whether the method of weight loss influences post-operative outcomes following panniculectomy. Methods A single-center retrospective review was conducted of patients who underwent panniculectomy between 2021 and 2025. Patients were grouped into four cohorts: lifestyle modifications alone, bariatric surgery, GLP-1 agonist therapy, or combined bariatric surgery and GLP-1 agonist therapy. Patients receiving abdominoplasty with extensive undermining and rectus plication were excluded. Variables of interest included patient demographics, weight loss history, comorbidities, wound healing complications, surgical site infection, hematoma/seroma, and hospital utilization. Multivariate logistic regression was performed to analyze post-operative complications and healthcare utilization, with statistical significance set at p < 0.05. Results A total of 281 patients met inclusion criteria (lifestyle modifications: n=53 (18.9%); bariatric surgery: n=184 (65.5%); GLP-1 agonist therapy: n=20 (7.1%); and combined bariatric surgery and GLP-1 agonist therapy: n=24 (8.5%)). Multivariate analysis showed no statistically significant differences in post-operative outcomes, including wound complications, surgical site infections, seroma/hematoma, or hospital utilization. Conclusions Post-operative outcomes following panniculectomy may be similar regardless of weight loss method. Pre-operative GLP-1 agonist therapy, alone or combined with bariatric surgery, was not associated with increased post-operative complications or healthcare utilization. Our results can help guide risk stratification and decision-making for individuals pursuing panniculectomy after weight loss.

Aesthetic Surgery Journal Open Forum
Indiana University – Purdue University Indianapolis (US)
Good health and well-being
Openalex Percentile: Top 10%
Body Contouring and Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.